Affinium Scores $15 Million In Series B Financing
This article was originally published in The Pink Sheet Daily
Executive Summary
The anti-infectives company raised $15 million to support the completion of Phase II testing for its oral antibiotic, as well as the initiation of Phase I trials for a new IV formulation.